A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. by Dominique L Braun, Andri Rauch, Manel Aouri, Nina Durisch, Nadia Eberhard, Alexia Anagnostopoulos, Bruno Ledergerber, Beat Müllhaupt, Karin J Metzner, Laurent Decosterd, Jürg Böni, Rainer Weber, Jan Fehr, Swiss HIV Cohort Study

Get full text